12935 Results

People

  1. Weigelt
    Weigelt
  2. Reis-Filho
    Reis-Filho
  3. Gonen
    Gonen
  4. Ladanyi
    Ladanyi
  5. Berger
    Berger
  6. Deasy
    Deasy
  7. Solit
    Solit
  8. Lewis
    Lewis
  9. Schultz
    Schultz
  10. De Stanchina
    De Stanchina

Groups

  1. Sloan Kettering Institute Postdocs (12935)
  2. GSK Faculty (6209)
  3. Department of Medicine (4655)
  4. Sloan Kettering Institute Faculty (3489)
  5. Surgery (2557)
  6. Solid Tumor Oncology Division (2525)
  7. Department of Pathology and Laboratory Medicine (2500)
  8. Center for Hematologic Malignancies (2323)
  9. Epidemiology and Biostatistics (1996)
  10. Human Oncology and Pathogenesis Program (1984)
  1. "Sloan Kettering Institute Postdocs"
Formats
  1. Journal Article (7820)
  2. Meeting Abstract (3611)
  3. Review (610)
  4. Editorial (251)
  5. Book Section (189)
  6. Conference Paper (160)
  7. Research Letter (133)
  8. Correspondence (63)
  9. Miscellaneous (62)
  10. Guidelines (30)
  11. Book Whole (6)
Groups
  1. Sloan Kettering Institute Postdocs (12935)
  2. GSK Faculty (6209)
  3. Department of Medicine (4655)
  4. Sloan Kettering Institute Faculty (3489)
  5. Surgery (2557)
  6. Solid Tumor Oncology Division (2525)

More Groups

People
  1. Britta Weigelt (366)
  2. Jorge Reis-Filho (327)
  3. Mithat Gonen (309)
  4. Marc Ladanyi (304)
  5. Joseph Deasy (278)
  6. Michael Berger (278)

More People

Years
  1. 2025 (393)
  2. 2024 (1038)
  3. 2023 (1151)
  4. 2022 (1364)
  5. 2021 (1176)
  6. 2020 (1240)

More Years

Publications
  1. Blood (641)
  2. Cancer Research (542)
  3. Journal of Clinical Oncology (416)
  4. Journal of Nuclear Medicine (261)
  5. Annals of Surgical Oncology (257)
  6. Clinical Cancer Research (235)

More Publications

Publishers
  1. Nature Publishing Group (1308)
  2. Elsevier Inc. (1173)
  3. American Association for Cancer Research (1039)
  4. Springer (818)
  5. Cell Press (719)
  6. American Society of Hematology (697)

More Publishers

Results (12935)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Use of response permutation to measure an imaging dataset's susceptibility to overfitting by selected standard analysis pipelines
    Journal Article

    Chakraborty, J.; Midya, A.; Kurland, B. F.; Welch, M. L.; Gonen, M.; Moskowitz, C. S.; Simpson, A. L.
    Academic Radiology (2024)

    Fulltext@MSK | Save
  • Protocol for generating human cortical organoidsenriched in outer radial glia by guided differentiation
    Journal Article

    Luongo, R.; Walsh, R. M.; Verrillo, A.; Studer, L.; Baggiolini, A.
    STAR Protocols (2024)

    Fulltext@MSK | Save
  • Multi-parametric atlas of the pre-metastatic liver for prediction of metastatic outcome in early-stage pancreatic cancer
    Journal Article

    Bojmar, L.; Zambirinis, C. P.; Hernandez, J. M.; Chakraborty, J.; Shaashua, L.; Kim, J.; Johnson, K. E.; Hanna, S.; Askan, G.; Burman, J.; more...
    Nature Medicine (2024)

    Fulltext@MSK | Save
  • Killing tumor-associated bacteria with a liposomal antibiotic generates neoantigens that induce anti-tumor immune responses
    Journal Article

    Wang, M.; Rousseau, B.; Qiu, K.; Huang, G.; Zhang, Y.; Su, H.; Le Bihan-Benjamin, C.; Khati, I.; Artz, O.; Foote, M. B.; more...
    Nature Biotechnology (2024)

    Fulltext@MSK | Save
  • Precursor central memory versus effector cell fate and naïve CD4+ T cell heterogeneity
    Journal Article

    Deep, D.; Gudjonson, H.; Brown, C. C.; Rose, S. A.; Sharma, R.; Iza, Y. A. P.; Hong, S. H.; Hemmers, S.; Schizas, M.; Wang, Z. M.; more...
    Journal of Experimental Medicine (2024)

    Fulltext@MSK | Save
  • Concordance in oncogenic alterations between the primary tumor and advanced disease: Insights into the heterogeneity of intrahepatic cholangiocarcinoma
    Journal Article

    McIntyre, S. M.; Preston, W. A.; Walch, H.; Sharib, J.; Kundra, R.; Sigel, C.; Lidsky, M. E.; Allen, P. J.; Morse, M. A.; Chen, W.; more...
    JCO Precision Oncology (2024)

    Fulltext@MSK | Save
  • Combination of MDM2 and targeted kinase inhibitors results in prolonged tumor control in lung adenocarcinomas with oncogenic tyrosine kinase drivers and MDM2 amplification
    Journal Article

    Elkrief, A.; Odintsov, I.; Smith, R. S.; Vojnic, M.; Hayashi, T.; Khodos, I.; Markov, V.; Liu, Z.; Lui, A. J. W.; Bloom, J. L.; more...
    JCO Precision Oncology (2024)

    Fulltext@MSK | Save
  • The FXR1 network acts as a signaling scaffold for actomyosin remodeling
    Journal Article

    Chen, X.; Fansler, M. M.; Janjoš, U.; Ule, J.; Mayr, C.
    Cell (2024)

    Fulltext@MSK | Save
  • Dotting out AML by targeting fibrillarin
    Editorial

    Luo, H.; Kharas, M. G.
    Cancer Research (2024)

    Fulltext@MSK | Save
  • Insights on future directions in cancer research from the AACR NextGen Stars
    Editorial

    Cañadas, I.; Casirati, G.; Houlahan, K. E.; Maxwell, K. N.; Mehta, A.; Parolia, A.; Saulnier, O.; Taylor, A. M.; Thomas, C. E.; Vázquez-García, I.
    Cancer Discovery (2024)

    Fulltext@MSK | Save